Read + Share
Cho BC, Hayashi H, Lee JS, Lee SH, et al. Amivantamab plus lazertinib versus osimertinib as first-line treatment in
EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset. Lung Cancer 2025;204:108496.
PMID: 40300278
|
 |
|
Cho BC, Hayashi H, Lee JS, Lee SH, et al. Amivantamab plus lazertinib versus osimertinib as first-line treatment in
EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset. Lung Cancer 2025;204:108496.
PMID: 40300278
|
|
|
|